Effects of Multiple High-Dose Methamphetamine Administration on Enteric Dopaminergic Neurons and Intestinal Motility in the Rat Model-Reference-Cited by-同舟云学术

Effects of Multiple High-Dose Methamphetamine Administration on Enteric Dopaminergic Neurons and Intestinal Motility in the Rat Model

Published:2023-09-27 Issue:6 Volume:41 Page:604-614
ISSN:1029-8428
Container-title:Neurotoxicity Research
language:en
Short-container-title:Neurotox Res

Author:

He Li,Zheng Huihui,Qiu Jilong,Chen Hong,Li Huan,Ma Yuejiao,Wang Yingying,Wang Qianjin,Hao Yuzhu,Liu Yueheng,Yang Qian,Wang Xin,Li Manyun,Xu Huixue,Peng Pu,Li Zejun,Zhou Yanan,Wu Qiuxia,Chen Shubao,Zhang Xiaojie,Liu Tieqiao

Funder

National Natural Science Foundation of China

The science and technology innovation Program of Hunan Province

Hunan Provincial Natural Science Foundation

Changsha Natural Science Foundation Project

Scientific Research Project of Hunan Provincial Health Commission

Publisher

Springer Science and Business Media LLC

Subject

Toxicology,General Neuroscience

Link

https://link.springer.com/content/pdf/10.1007/s12640-023-00668-x.pdf

Reference62 articles.

1. Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S, Greene JG (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson’s disease. Exp Neurol 207:4–12

2. Ares-Santos S, Granado N, Espadas I, Martinez-Murillo R, Moratalla R (2014) Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining. Neuropsychopharmacology 39:1066–1080

3. Baucum AJ, 2nd, Rau KS, Riddle EL, Hanson GR, Fleckenstein AE (2004) Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism. J Neurosci24:3436–43

4. Bray GA (1993) Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med 119:707–713

5. Cadet JL (2016) Epigenetics of stress, addiction, and resilience: therapeutic implications. Mol Neurobiol 53:545–560